• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

Axogen info

Quote

anonymous

Guest
What is the latest with Axogen? Are they surviving - or thriving? I heard rumors of a breast repair/salvage product?

Have they figured out a legit way to come up with an honest/fair quota yet?
 




Nope. They will hit their peak in about a year and then it will be all down hill from there. They still aren’t profitable.. even being the only company with a true Nerve allograft option.
 




anonymous said:
What is the latest with Axogen? Are they surviving - or thriving? I heard rumors of a breast repair/salvage product?

Have they figured out a legit way to come up with an honest/fair quota yet?
Click to expand...

the 'product' is still just avance, just a new indication. breast recon docs have been doing it for years under the table for double mastectomy reinnervations - they can just finally market and make money on it now. while YOU stay poor
 








Top Bottom
Back
Quote